Health
UIC conducts three clinical trials to study blood clot prevention in COVID-19 patients – News-Medical.Net
The University of Illinois Chicago will conduct three clinical trials for studying blood clot prevention in patients with COVID-19.
Reviewed by Emily Henderson, B.Sc.Nov 18 2020
The University of Illinois Chicago will conduct three clinical trials for studying blood clot prevention in patients with COVID-19.
Blood clots are one of the leading complications of COVID-19. Patients with COVID-19 often form blood clots throughout their bodies, which, if untreated, can lead to organ damage, including stroke, pulmonary embolism and heart attacks. We need to stop blood clot formation in order to prevent these potentially fatal complications…
-
Noosa News22 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News21 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
Business7 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General17 hours ago‘Potential’ hacker contacts Qantas over data breach